相关实验视频

Updated: Jun 2, 2025

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

胎儿瘤基因NUAK2是质母细胞瘤中一个新兴的治疗点

Hanhee Jo^1,2, Aneesh Dalvi¹, Wenqi Yang¹

¹Neurobiology Department, School of Biological Sciences, University of California San Diego, La Jolla, 92093 CA, USA.

bioRxiv : the preprint server for biology

|January 13, 2025

概括

胎儿瘤基因NUAK2在多种质母细胞瘤 (GBM) 中重新表达. 抑制NUAK2抑制了GBM细胞的增殖和迁移,这表明它是潜在的治疗点大脑癌症.

科学领域:

神经瘤学神经瘤学
分子生物学分子生物学
癌症遗传学癌症遗传学

背景情况:

多形质母细胞瘤 (GBM) 是一种具有有限治疗选择的侵袭性脑癌.
神经发育基因的重新表达,如NUAK2,在质瘤瘤发生过程中被观察到.

研究的目的:

调查NUAK家族激酶2 (NUAK2) 在多形质母细胞瘤 (GBM) 发育和进展中的作用.
评估NUAK2作为GBM潜在的治疗点.

主要方法:

在GBM细胞中,CRISPR-Cas9介导的基因删除和NUAK2的过度表达.
在体外和体内生殖的增殖和迁移测试.
药物抑制NUAK2.2的作用

主要成果:

删除NUAK2抑制了GBM细胞的增殖,而过度表达增强了它.
AK2调节细胞外基质组件,促进质瘤细胞迁移.
药物抑制NUAK2有效地阻碍了GBM细胞的增殖和迁移.

结论:

NUAK2 作为胎儿瘤基因,促进了 GBM 瘤发生.
努阿克2是质母细胞瘤治疗的可行和可行的治疗点.

更多相关视频

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Published on: February 24, 2023

Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing

Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing

Published on: June 9, 2016

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Enzyme-linked Receptors

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...